This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignees: Daegu-Gyeongbuk Medical Innovation Foundation, Omic Smap Inc., Pimedbio, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 10 
1 out of 1 
1 out of 1 Years Active: 2026
Title: Jeong-Eun Park: Innovator in Pharmaceutical Applications
Introduction
Jeong-Eun Park is a notable inventor based in Daegu, South Korea. She has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. Although she currently holds no granted patents, her work in innovative compounds and methods showcases her potential in the industry.
Latest Patent Applications
Jeong-Eun Park has filed several patent applications that highlight her research and development efforts. One of her latest applications is for a compound titled "Quinazoline-2,4-Diamine Derivative and Pharmaceutical Composition for Preventing or Treating Cancer Comprising Same as Active Ingredient." This compound exhibits a high inhibitory ability on euchromatic histone-lysine N-methyltransferase 2 (EHMT2), making it a promising candidate for cancer treatment. Another application is for a "Novel Compound, Preparation Method Thereof, and Use Thereof," which relates to a method for preparing a biomaterial with selectively functionalized tyrosine. This method allows for high-yield coupling of the compound to tyrosine, maintaining the inherent activity of the biomaterial and enhancing its pharmaceutical applications.
Conclusion
Jeong-Eun Park's innovative work in pharmaceutical applications demonstrates her commitment to advancing cancer treatment. Her latest patent applications reflect her potential to contribute significantly to the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile